FDA Inspection
CorneaGenCorneaGen – FDA Inspection, Aug 22, 2016
Record Details
This FDA Inspection record concerns CorneaGen, with an inspection on August 22, 2016, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- CorneaGen
- Inspection Date
- August 22, 2016
- Product Type
- Biologics
View Company Profile
ID · f2f0a1a7-8206-454e-9926-5dfa45e07f57
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 981338
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
Other FDA inspections of CorneaGen
7| Date | Classification | Office | Project area |
|---|---|---|---|
| September 22, 2026 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| September 15, 2021 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| September 14, 2018 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| March 25, 2014 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| November 16, 2012 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for CorneaGen
- FDA Inspection 1338912 - 2026-09-22
- FDA Inspection 1153003 - 2021-09-15
- FDA Inspection 1068567 - 2018-09-14
- FDA Inspection 872226 - 2014-03-25
- FDA Inspection 807888 - 2012-11-16
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.